Sepsis is a systemic inflammatory response against microbial infections, which can lead to organ dysfunction or failure. It is possible by pathogenic microorganisms, including bacterial, viral, fungal, or parasitic organisms, that can easily enter the bloodstream. As a result, they can arise infection at a localized site of infection such as the lung or urogenital tract. On the other hand, the entry of microorganisms into the bloodstream is also possible via skin breaks and also caused by surgery or the insertion of catheters during hospital treatment. In turn, systemic immune responses can cause severe symptoms, including elevated heart rate and rapid breathing or severe fever. It is a potentially lethal condition that can leads directly to death. To identify the causative agent, sepsis Diagnostics is performed. Sepsis occurs in a condition when an immune system of the host responds to an infection, and then chemicals released to treat the infection.
The "Global Sepsis Diagnostics Market Analysis to 2028" is a specialized and in-depth study of the biotechnology industry with a special focus on the global market trend analysis. The report aims to provide an overview of the sepsis diagnostics market with detailed market segmentation by product, technology, test type, pathogen end user, and geography. The report provides key statistics on the market status of the leading Sepsis Diagnostics market players and offers key trends and opportunities in the market.
- Based on product, the global sepsis diagnostics market is segmented into instruments, reagents and assays, blood culture media, software.
- On the basis of technology, the market is segmented molecular diagnostics, flow cytometry, microfluidics, immunoassay, biomarkers, microbiology.
- Based on method, the market is bifurcated into automated diagnostics, conventional diagnostics.
- Based on test type, the market is bifurcated into point-of-care tests, laboratory tests.
- Based on pathogen, the market is bifurcated into bacterial sepsis, fungal sepsis, others.
- Based on end user, the market is bifurcated into hospitals, pathology and reference laboratories, others.
- High incidence of hospital-acquired infections
- Increasing government initiatives for creating sepsis awareness
- Rising geriatric population across the globe
- Growing adoption of open innovation models in pharmaceutical & biotechnology companies.
- High cost of automated diagnostic devices
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The sepsis diagnostics market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.
The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the marketduring the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the sepsis diagnostics market in these regions.
IMPACT OF COVID-19 ON HIGH THROUGHPUT SCREENINGMARKET
COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in global market. Few companies have already announced possible delays in product deliveries and slump in future sales of their products. In addition to this, the global travel bans imposed by countries in Europe, Asia-Pacific, and North America are affecting the business collaborations and partnerships opportunities.
The report covers key developments in the sepsis diagnostics market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from Sepsis DiagnosticsMarket are anticipated to lucrative growth opportunities in the future with the rising demand for sepsis diagnostics in the global market.
The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the sepsis diagnostics market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.
- F. Hoffmann-La Roche Ltd
- Thermo Fisher Scientific Inc.
- T2 Biosystems, Inc.
- Luminex Corporation
- Axis-Shield Diagnostics Ltd.
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.